LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | JW-7-24-1 | 10 | uM | LJP6 | 1 | B19 | 72 | hr | 1401 | 1221 | 4139 | 0.2950 | -0.0845 |
| SK-BR-3 | JW-7-24-1 | 10 | uM | LJP6 | 2 | B19 | 72 | hr | 1401 | 1110 | 4095 | 0.2710 | -0.1399 |
| SK-BR-3 | JW-7-24-1 | 10 | uM | LJP6 | 3 | B19 | 72 | hr | 1401 | 1298 | 4272 | 0.3038 | -0.0466 |
| SK-BR-3 | Dasatinib | 0.04 | uM | LJP6 | 1 | I06 | 72 | hr | 1401 | 3732 | 4139 | 0.9017 | 0.8718 |
| SK-BR-3 | Dasatinib | 0.04 | uM | LJP6 | 2 | I06 | 72 | hr | 1401 | 4122 | 4095 | 1.0065 | 1.0084 |
| SK-BR-3 | Dasatinib | 0.04 | uM | LJP6 | 3 | I06 | 72 | hr | 1401 | 3545 | 4272 | 0.8298 | 0.7808 |
| SK-BR-3 | Dasatinib | 0.04 | uM | LJP5 | 1 | D06 | 72 | hr | 1401 | 4257 | 3978 | 1.0700 | 1.0919 |
| SK-BR-3 | Dasatinib | 0.04 | uM | LJP5 | 2 | D06 | 72 | hr | 1401 | 4675 | 4213 | 1.1096 | 1.1354 |
| SK-BR-3 | Dasatinib | 0.04 | uM | LJP5 | 3 | D06 | 72 | hr | 1401 | 4337 | 4545 | 0.9540 | 0.9453 |
| SK-BR-3 | Dasatinib | 0.12 | uM | LJP6 | 1 | I05 | 72 | hr | 1401 | 4163 | 4139 | 1.0058 | 1.0074 |
| SK-BR-3 | Dasatinib | 0.12 | uM | LJP6 | 2 | I05 | 72 | hr | 1401 | 4041 | 4095 | 0.9867 | 0.9828 |
| SK-BR-3 | Dasatinib | 0.12 | uM | LJP6 | 3 | I05 | 72 | hr | 1401 | 3351 | 4272 | 0.7843 | 0.7196 |
| SK-BR-3 | Dasatinib | 0.12 | uM | LJP5 | 1 | D05 | 72 | hr | 1401 | 4250 | 3978 | 1.0682 | 1.0896 |
| SK-BR-3 | Dasatinib | 0.12 | uM | LJP5 | 2 | D05 | 72 | hr | 1401 | 4665 | 4213 | 1.1072 | 1.1325 |
| SK-BR-3 | Dasatinib | 0.12 | uM | LJP5 | 3 | D05 | 72 | hr | 1401 | 4491 | 4545 | 0.9879 | 0.9857 |
| SK-BR-3 | Dasatinib | 0.37 | uM | LJP6 | 1 | I04 | 72 | hr | 1401 | 3983 | 4139 | 0.9623 | 0.9514 |
| SK-BR-3 | Dasatinib | 0.37 | uM | LJP6 | 2 | I04 | 72 | hr | 1401 | 4336 | 4095 | 1.0588 | 1.0752 |
| SK-BR-3 | Dasatinib | 0.37 | uM | LJP6 | 3 | I04 | 72 | hr | 1401 | 3194 | 4272 | 0.7476 | 0.6690 |
| SK-BR-3 | Dasatinib | 0.37 | uM | LJP5 | 1 | D04 | 72 | hr | 1401 | 3952 | 3978 | 0.9933 | 0.9911 |
| SK-BR-3 | Dasatinib | 0.37 | uM | LJP5 | 2 | D04 | 72 | hr | 1401 | 4491 | 4213 | 1.0659 | 1.0820 |
| SK-BR-3 | Dasatinib | 0.37 | uM | LJP5 | 3 | D04 | 72 | hr | 1401 | 4480 | 4545 | 0.9855 | 0.9829 |
| SK-BR-3 | Dasatinib | 1.11 | uM | LJP6 | 1 | I03 | 72 | hr | 1401 | 3275 | 4139 | 0.7913 | 0.7216 |
| SK-BR-3 | Dasatinib | 1.11 | uM | LJP6 | 2 | I03 | 72 | hr | 1401 | 3678 | 4095 | 0.8981 | 0.8658 |
| SK-BR-3 | Dasatinib | 1.11 | uM | LJP6 | 3 | I03 | 72 | hr | 1401 | 3064 | 4272 | 0.7172 | 0.6265 |
| SK-BR-3 | Dasatinib | 1.11 | uM | LJP5 | 1 | D03 | 72 | hr | 1401 | 3649 | 3978 | 0.9172 | 0.8884 |